Women’s health trial expansion
Phase IIIb preterm delivery study expands to additional locations in Serbia, Romania, and Bulgaria under GCT management, making our team responsible for this project at 45 sites in 7 countries.
The Sponsor, a US pharmaceutical company, thus shows confidence in GCT international capabilities and local expertise.
Updated: August 28, 2015
Permanent link: https://2022.gctrials.com/news/womens-health-trial-expansion/